Cerebyx Injection, Solution
Product Images NDC 0069-5474

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Cerebyx (NDC 0069-5474). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Cerebyx 01)

Chemical structure of fosphenytoin sodium, the active ingredient in CEREBYX injection solution. The diagram shows the molecular arrangement with sodium ions indicated.*

FDA Label Image

Figure 1 (Cerebyx 02)

A pharmacokinetic graph showing plasma unbound phenytoin concentration (µg/mL) versus time after start of infusion (hours). The main chart covers 0 to 2 hours, and an inset graph extends from 0 to 96 hours. The data points are represented by different shapes connected with lines, illustrating concentration changes over time during and after infusion.*

FDA Label Image

Logo (Cerebyx 03)

FDA Label Image

Principal Display Panel (10 mL Vial Label)

Cerebyx (fosphenytoin sodium) Injection 50 mg PE/mL in a 10 mL single-dose vial label. The label states it is intended for intramuscular or intravenous use, with each vial containing 500 mg phenytoin sodium equivalents. The product is stored under refrigeration and distributed by Pfizer Labs.*

FDA Label Image

Principal Display Panel (10 mL Vial Package)

CEREBYX (fosphenytoin sodium) Injection 500 mg PE/10 mL (50 mg PE/mL) solution for injection, indicated for intramuscular or intravenous use. The label shows a carton for 10 single-dose vials, distributed by Pfizer Laboratories Div Pfizer Inc. The label includes dosage strength in phenytoin sodium equivalents (PE) and highlights storage and usage instructions.*

FDA Label Image

Principal Display Panel (2 mL Vial Label)

Label for Cerebyx (fosphenytoin sodium) injection, 100 mg PE/2 mL (50 mg PE/mL), human prescription drug available as an injection solution for intramuscular or intravenous use. The label mentions the product is distributed by Pfizer Laboratories, division of Pfizer Inc, NY. It specifies dosage information and packaging as a 2 mL single-dose vial.*

FDA Label Image

Principal Display Panel (2 mL Vial Carton)

Packaging label for Cerebyx (fosphenytoin sodium) Injection, 100 mg PE/2 mL (50 mg PE/mL), in single-dose vials (2 mL each). Indicated for intramuscular or intravenous use, distributed by Pfizer Labs, a division of Pfizer Inc. The label includes storage and dosage information, barcode, and the Novaplus trademark.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.